Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3‐year retrospective cohort study
Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objec...
Saved in:
Published in | Transplant infectious disease Vol. 19; no. 4 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Wiley Subscription Services, Inc
01.08.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1398-2273 1399-3062 1399-3062 |
DOI | 10.1111/tid.12724 |
Cover
Abstract | Background
In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.
Objectives
We compared the 3‐year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.
Methods
This was an observational, retrospective, double‐center study, including all HIV‐infected patients >18 years old undergoing KT.
Results
Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co‐infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy‐proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir‐based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.
Conclusion
Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non‐AIDS infections leading to early mortality in Brazil deserve special attention. |
---|---|
AbstractList | In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.
We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.
This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT.
Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.
Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention. Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objectives We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. Methods This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT. Results Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Conclusion Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention. In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.BACKGROUNDIn the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes.We compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.OBJECTIVESWe compared the 3-year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development.This was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT.METHODSThis was an observational, retrospective, double-center study, including all HIV-infected patients >18 years old undergoing KT.Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.RESULTSBetween 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co-infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy-proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir-based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections.Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention.CONCLUSIONImportant regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non-AIDS infections leading to early mortality in Brazil deserve special attention. Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries concentrate 90% of the people living with HIV, but their experience is underreported. Regional differences may affect outcomes. Objectives We compared the 3‐year outcomes of patients with HIV infection receiving a KT in two different countries, in terms of incomes and development. Methods This was an observational, retrospective, double‐center study, including all HIV‐infected patients >18 years old undergoing KT. Results Between 2005 and 2015, 54 KTs were performed (39 in a Brazilian center, and 15 in a Spanish center). Brazilians had less hepatitis C virus co‐infection (5% vs 27%, P=.024). Median cold ischemia time was higher in Brazil (25 vs 18 hours, P=.001). Biopsy‐proven acute rejection (AR) was higher in Brazil (33% vs 13%, P=.187), as were the number of AR episodes (22 vs 4, P=.063). Patient survival at 3 years was 91.3% in Brazil and 100% in Spain; P=.663. All three cases of death in Brazil were a result of bacterial infections within the first year post transplant. At 3 years, survival free from immunosuppressive changes was lower in Brazil (56% vs 90.9%, P=.036). Raltegravir‐based treatment to avoid interaction with calcineurin inhibitor was more prevalent in Spain (80% vs 3%; P<.001). HIV infection remained under control in all patients, with undetectable viral load and no opportunistic infections. Conclusion Important regional differences exist in the demographics and management of immunosuppression and antiretroviral therapy. These details may influence AR and infectious complications. Non‐AIDS infections leading to early mortality in Brazil deserve special attention. |
Author | Agüero, Fernando Musquera, M. Cristelli, Marina P. Marcos, M.A. Revuelta, I. Medina‐Pestana, Jose O. Alcaraz, A. Ricart, M.J. Torregrosa, J.V. Tuset, M. Cofán, Federico Soy, D. Diekmann, Fritz Blanco, J.L. Miro, Jose Maria Paredes, D. Oppenheimer, Federico Bodro, M. Manzardo, Christian Mosquera, M.D. Trullàs, Joan Carles Garcia, F. Esforzado, N. Santos, Daniel Wagner C. L. Ambrosioni, J. Tedesco‐Silva, Helio Moreno, Asunción Martinez, E. Mallolas, J. Peri, L. Brunet, M. |
Author_xml | – sequence: 1 givenname: Marina P. orcidid: 0000-0002-2813-0400 surname: Cristelli fullname: Cristelli, Marina P. organization: UNIFESP – sequence: 2 givenname: Federico surname: Cofán fullname: Cofán, Federico organization: University of Barcelona – sequence: 3 givenname: Helio surname: Tedesco‐Silva fullname: Tedesco‐Silva, Helio organization: UNIFESP – sequence: 4 givenname: Joan Carles surname: Trullàs fullname: Trullàs, Joan Carles organization: University of Girona – sequence: 5 givenname: Daniel Wagner C. L. surname: Santos fullname: Santos, Daniel Wagner C. L. organization: UNIFESP – sequence: 6 givenname: Christian surname: Manzardo fullname: Manzardo, Christian organization: University of Barcelona – sequence: 7 givenname: Fernando surname: Agüero fullname: Agüero, Fernando organization: University of Barcelona – sequence: 8 givenname: Asunción surname: Moreno fullname: Moreno, Asunción organization: University of Barcelona – sequence: 9 givenname: Federico surname: Oppenheimer fullname: Oppenheimer, Federico organization: University of Barcelona – sequence: 10 givenname: Fritz surname: Diekmann fullname: Diekmann, Fritz organization: University of Barcelona – sequence: 11 givenname: Jose O. surname: Medina‐Pestana fullname: Medina‐Pestana, Jose O. organization: UNIFESP – sequence: 12 givenname: Jose Maria surname: Miro fullname: Miro, Jose Maria email: jmmiro@ub.edu organization: University of Barcelona – sequence: 14 givenname: A. surname: Alcaraz fullname: Alcaraz, A. – sequence: 15 givenname: J. surname: Ambrosioni fullname: Ambrosioni, J. – sequence: 16 givenname: M. surname: Bodro fullname: Bodro, M. – sequence: 17 givenname: J.L. surname: Blanco fullname: Blanco, J.L. – sequence: 18 givenname: M. surname: Brunet fullname: Brunet, M. – sequence: 19 givenname: F. surname: Garcia fullname: Garcia, F. – sequence: 20 givenname: D. surname: Paredes fullname: Paredes, D. – sequence: 21 givenname: N. surname: Esforzado fullname: Esforzado, N. – sequence: 22 givenname: M.A. surname: Marcos fullname: Marcos, M.A. – sequence: 23 givenname: J. surname: Mallolas fullname: Mallolas, J. – sequence: 24 givenname: E. surname: Martinez fullname: Martinez, E. – sequence: 25 givenname: M.D. surname: Mosquera fullname: Mosquera, M.D. – sequence: 26 givenname: M. surname: Musquera fullname: Musquera, M. – sequence: 27 givenname: L. surname: Peri fullname: Peri, L. – sequence: 28 givenname: I. surname: Revuelta fullname: Revuelta, I. – sequence: 29 givenname: M.J. surname: Ricart fullname: Ricart, M.J. – sequence: 30 givenname: D. surname: Soy fullname: Soy, D. – sequence: 31 givenname: J.V. surname: Torregrosa fullname: Torregrosa, J.V. – sequence: 32 givenname: M. surname: Tuset fullname: Tuset, M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28508573$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctu1jAQhS1URC-w4AWQJTawSOtbLmZXFWgrVUJCZR05zri_S2IH22mVXR-h78Fb8SQ4_QuLSuCNR5rvnNHM2Uc7zjtA6DUlhzS_o2T7Q8pqJp6hPcqlLDip2M5D3RSM1XwX7cd4TQitpZAv0C5rStKUNd9DP7_ClfVODbi3xkAApyFi63DaAB6VU1cwgktYuR77OWk_AvYGf7e9gwWnoFycBuWSStll1U25yoKIb23a4M2cPbAdx9n5HozVuacXfGPDvE4xoFfdB3yM-a-7-wVUwAFS8HFaOzeAtd_4kHBMc7-8RM-NGiK8evwP0LfPny5PzoqLL6fnJ8cXheYlFwVlomnAEFMBU1Ap0qm6kqA7I4VSgnYgJReGkV6UhMmyIkJVnSaacuhr0vED9G7rOwX_Y4aY2tFGDUPeE_wcW9pIKUhVVTyjb5-g134O-ZyZkqwsaUNrkqk3j9TcjdC3U7CjCkv7J4YMvN8COq8eA5i_CCXtGnGbI24fIs7s0RNW2-35cxp2-J_i1g6w_Nu6vTz_uFX8BgXyvAM |
CitedBy_id | crossref_primary_10_1186_s12981_019_0253_z crossref_primary_10_1007_s11904_019_00440_x crossref_primary_10_1186_s12879_024_10026_7 crossref_primary_10_1111_tid_13511 |
Cites_doi | 10.1681/ASN.2014070726 10.1089/aid.2007.0015 10.1093/cid/ciu617 10.7326/0003-4819-150-9-200905050-00006 10.5935/0101-2800.20120029 10.1093/ndt/gfs287 10.1111/tid.12592 10.1097/QAI.0000000000000291 10.1002/bjs.6607 10.1056/NEJMoa1408896 10.1111/ajt.13840 10.1056/NEJMc0900837 10.1111/j.1600-6143.2008.02159.x 10.1038/ki.2010.545 10.1016/j.transproceed.2009.04.013 10.1111/j.1600-6143.2010.03258.x 10.5123/S1679-49742012000300013 10.1016/S1473-3099(15)00056-0 10.1097/TP.0000000000000879 10.1097/TP.0b013e31829df29d 10.1038/ki.2015.74 10.1111/j.1432-2277.2010.01204.x 10.5935/0101-2800.20140049 10.1056/NEJMoa1001197 10.1111/j.1600-6143.2009.02684.x 10.1111/j.1600-6143.2006.01238.x 10.1093/ndt/gfq592 10.1681/ASN.2013050564 10.1681/ASN.2014121234 10.5935/0101-2800.20130048 10.1016/S0140-6736(13)61809-7 10.1097/01.TP.0000436905.54640.8c 10.1590/S0101-28002011000400014 |
ContentType | Journal Article |
Contributor | Mosquera, M D Soy, D Tuset, M Alcaraz, A Ambrosioni, J Paredes, D Esforzado, N Marcos, M A Martinez, E Torregrosa, J V Peri, L Blanco, J L Revuelta, I Ricart, M J Mallolas, J Musquera, M Garcia, F Bodro, M Brunet, M |
Contributor_xml | – sequence: 1 givenname: A surname: Alcaraz fullname: Alcaraz, A – sequence: 2 givenname: J surname: Ambrosioni fullname: Ambrosioni, J – sequence: 3 givenname: M surname: Bodro fullname: Bodro, M – sequence: 4 givenname: J L surname: Blanco fullname: Blanco, J L – sequence: 5 givenname: M surname: Brunet fullname: Brunet, M – sequence: 6 givenname: F surname: Garcia fullname: Garcia, F – sequence: 7 givenname: D surname: Paredes fullname: Paredes, D – sequence: 8 givenname: N surname: Esforzado fullname: Esforzado, N – sequence: 9 givenname: M A surname: Marcos fullname: Marcos, M A – sequence: 10 givenname: J surname: Mallolas fullname: Mallolas, J – sequence: 11 givenname: E surname: Martinez fullname: Martinez, E – sequence: 12 givenname: M D surname: Mosquera fullname: Mosquera, M D – sequence: 13 givenname: M surname: Musquera fullname: Musquera, M – sequence: 14 givenname: L surname: Peri fullname: Peri, L – sequence: 15 givenname: I surname: Revuelta fullname: Revuelta, I – sequence: 16 givenname: M J surname: Ricart fullname: Ricart, M J – sequence: 17 givenname: D surname: Soy fullname: Soy, D – sequence: 18 givenname: J V surname: Torregrosa fullname: Torregrosa, J V – sequence: 19 givenname: M surname: Tuset fullname: Tuset, M |
Copyright | 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. 2017 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. – notice: 2017 Wiley Periodicals, Inc. |
CorporateAuthor | the Sao Paulo‐Barcelona Renal Transplant in HIV Investigators Sao Paulo-Barcelona Renal Transplant in HIV Investigators |
CorporateAuthor_xml | – name: the Sao Paulo‐Barcelona Renal Transplant in HIV Investigators – name: Sao Paulo-Barcelona Renal Transplant in HIV Investigators |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7U9 8FD FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1111/tid.12724 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1399-3062 |
EndPage | n/a |
ExternalDocumentID | 28508573 10_1111_tid_12724 TID12724 |
Genre | article Multicenter Study Journal Article Observational Study |
GeographicLocations | Brazil Spain |
GeographicLocations_xml | – name: Spain – name: Brazil |
GrantInformation_xml | – fundername: RETIC, Red de Sida funderid: #24‐0858‐09; RD12/0017/0001 – fundername: Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain) funderid: #24‐0858‐09; RD12/0017/0001 – fundername: FEDER – fundername: Departament de Salut de la Generalitat de Catalunya – fundername: Ministerio de Economía y Competitividad, Madrid (Spain) funderid: INT15/00168 – fundername: Instituto de Salud Carlos III, Madrid, Spain |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OC 29Q 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADXAS ADZCM AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION AEUQT AFPWT CGR CUY CVF ECM EIF NPM WRC 7QO 7U9 8FD FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3534-12488ef0f6e2ae6a0ba769ecbf94aa41be9934f20d450295604a6bc0c13ed70b3 |
IEDL.DBID | DR2 |
ISSN | 1398-2273 1399-3062 |
IngestDate | Fri Jul 11 00:44:42 EDT 2025 Sun Jul 13 03:31:39 EDT 2025 Wed Feb 19 02:44:20 EST 2025 Tue Jul 01 01:27:16 EDT 2025 Thu Apr 24 23:04:00 EDT 2025 Sun Sep 21 06:19:21 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | regional differences patient survival acute rejection antiretroviral therapy kidney transplantation Brazil graft survival HIV infection Spain |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3534-12488ef0f6e2ae6a0ba769ecbf94aa41be9934f20d450295604a6bc0c13ed70b3 |
Notes | Funding information The study was partially funded by the Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain) grant #24‐0858‐09 and by the RETIC, Red de Sida RD12/0017/0001, FEDER, Instituto de Salud Carlos III, Madrid, Spain. J.M.M. received a personal intensification research grant #INT15/00168 during 2016 from the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid (Spain), and a personal 80:20 research grant from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain during 2017‐19. C.M. received a personal post‐doctoral research grant (Pla Estratègic de Recerca i Innovació en Salut ‐PERIS‐ 2016/2020) from the ‘Departament de Salut de la Generalitat de Catalunya’, Barcelona, Catalonia, Spain during 2017‐2020. 1 See Appendix . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-2813-0400 |
PMID | 28508573 |
PQID | 1925518170 |
PQPubID | 1096379 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1899406663 proquest_journals_1925518170 pubmed_primary_28508573 crossref_primary_10_1111_tid_12724 crossref_citationtrail_10_1111_tid_12724 wiley_primary_10_1111_tid_12724_TID12724 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2017 2017-08-00 2017-Aug 20170801 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: August 2017 |
PublicationDecade | 2010 |
PublicationPlace | Denmark |
PublicationPlace_xml | – name: Denmark – name: Malden |
PublicationTitle | Transplant infectious disease |
PublicationTitleAlternate | Transpl Infect Dis |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2015; 15 2010; 10 2009; 41 2013; 28 2012 2010; 363 2011; 33 2016; 100 2014; 25 2010; 362 2008; 8 2006; 6 2011; 79 2009; 150 2013; 382 2016; 18 2012; 34 2016; 16 2014; 67 2015; 372 2015; 26 2009; 96 2013; 35 2015; 88 2006; 26 2013; 96 2014; 59 2009; 9 2014; 36 2011; 24 2015 2011; 26 2013 2007; 23 2014; 34 2012; 21 2014; 97 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 Mazuecos A (e_1_2_6_13_1) 2006; 26 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 González‐García J (e_1_2_6_29_1) 2012 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 Panel de Expertos del Grupo de Estudio de SIDA (GESIDA), la Sociedad Española de Nefrología (S.E.N.) y la Sociedad Española de Bioquímica Clínica y Patología Molecular (SEQC) (e_1_2_6_11_1) 2014; 34 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 18 start-page: 730 year: 2016 end-page: 740 article-title: Renal transplantation in human immunodeficiency virus‐infected recipients: A case‐control study from the Brazilian experience publication-title: Transpl Infect Dis – volume: 41 start-page: 3667 year: 2009 end-page: 3670 article-title: Risk factors associated with graft loss and patient survival after kidney transplantation publication-title: Transplant Proc – volume: 88 start-page: 341 year: 2015 end-page: 349 article-title: Superior outcomes in HIV‐positive kidney transplant patients compared with HCV‐infected or HIV/HCV‐coinfected recipients publication-title: Kidney Int – volume: 96 start-page: 685 year: 2009 end-page: 691 article-title: Case‐matched comparison of long‐term results of non‐heart beating and heart‐beating donor renal transplants publication-title: Br J Surg – volume: 23 start-page: 1161 year: 2007 end-page: 1165 article-title: Effect of thymoglobulin induction on HIV‐infected renal transplant recipients: Differences between HIV‐positive and HIV‐negative patients publication-title: AIDS Res Hum Retroviruses – volume: 67 start-page: 177 year: 2014 end-page: 180 article-title: End‐stage kidney disease and kidney transplantation in HIV‐positive patients: An observational cohort study publication-title: J Acquir Immune Defic Syndr – volume: 34 start-page: 387 year: 2012 end-page: 391 article-title: Kidney transplantation in HIV positive patients: Two case reports from Hospital de Clínicas de Porto Alegre initial experience publication-title: J Bras Nefrol – volume: 26 start-page: 3114 year: 2015 end-page: 3122 article-title: Adverse outcomes of tacrolimus withdrawal in immune‐quiescent kidney transplant recipients publication-title: J Am Soc Nephrol – volume: 79 start-page: 825 year: 2011 end-page: 842 article-title: Renal transplantation in HIV‐infected patients: 2010 update publication-title: Kidney Int – volume: 35 start-page: 289 year: 2013 end-page: 298 article-title: Influence of deceased donor hemodynamic factors in transplant recipients renal function publication-title: J Bras Nefrol – volume: 36 start-page: 339 year: 2014 end-page: 351 article-title: Risk assessment score in pre‐kidney transplantation: Methodology and the socioeconomic characteristics importance publication-title: J Bras Nefrol – volume: 25 start-page: 407 year: 2014 end-page: 419 article-title: The kidney as a reservoir for HIV‐1 after renal transplantation publication-title: J Am Soc Nephrol – volume: 10 start-page: 2263 year: 2010 end-page: 2269 article-title: Renal transplantation in HIV‐infected patients: The Paris experience publication-title: Am J Transplant – volume: 6 start-page: 753 year: 2006 end-page: 760 article-title: Thymoglobulin‐associated Cd4 T‐cell depletion and infection risk in HIV‐infected renal transplant recipients publication-title: Am J Transplant – volume: 26 start-page: 113 year: 2006 end-page: 120 article-title: Renal transplantation in HIV‐infected patients in Spain publication-title: Nefrología – volume: 8 start-page: 753 year: 2008 end-page: 760 article-title: Banff 07 classification of renal allograft pathology: Updates and future directions publication-title: Am J Transplant – volume: 372 start-page: 613 year: 2015 end-page: 620 article-title: HIV‐positive‐to‐HIV‐positive kidney transplantation‐results at 3 to 5 years publication-title: N Engl J Med – volume: 363 start-page: 2004 year: 2010 end-page: 2014 article-title: Outcomes of kidney transplantation in HIV‐infected recipients publication-title: N Engl J Med – year: 2012 – volume: 26 start-page: 2222 year: 2015 end-page: 2229 article-title: A national study of outcomes among HIV‐Infected kidney transplant recipients publication-title: J Am Soc Nephrol – volume: 100 start-page: 871 year: 2016 end-page: 878 article-title: Impact of tacrolimus compared with cyclosporin on the incidence of acute allograft rejection in human immunodeficiency virus‐positive kidney transplant recipients publication-title: Transplantation – volume: 21 start-page: 475 year: 2012 end-page: 486 article-title: Co‐infection of hepatitis B or C and human immunodeficiency virus: An exploratory study in the State of São Paulo, Brazil, 2007 to 2010 publication-title: Epidemiol Serv Saúde – volume: 28 start-page: 213 year: 2013 end-page: 220 article-title: Comparison of the long‐term outcomes of kidney transplantation: USA versus Spain publication-title: Nephrol Dial Transplant – volume: 33 start-page: 472 year: 2011 end-page: 484 article-title: Kidney transplantation in Brazil and its geographic disparity publication-title: J Bras Nefrol – volume: 382 start-page: 1525 year: 2013 end-page: 1533 article-title: The end of AIDS: HIV infection as a chronic disease publication-title: Lancet – volume: 97 start-page: 446 year: 2014 end-page: 450 article-title: Immunosuppression regimen and the risk of acute rejection in HIV‐infected kidney transplant recipients publication-title: Transplantation – volume: 26 start-page: 1401 year: 2011 end-page: 1407 article-title: HIV infection and renal transplantation publication-title: Nephrol Dial Transplant – volume: 150 start-page: 604 year: 2009 end-page: 612 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann Intern Med – volume: 362 start-page: 2336 year: 2010 end-page: 2337 article-title: Renal transplantation between HIV‐positive donors and recipients publication-title: N Engl J Med – volume: 16 start-page: 2368 year: 2016 end-page: 2376 article-title: Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus publication-title: Am J Transplant – volume: 15 start-page: 810 year: 2015 end-page: 818 article-title: Future challenges for clinical care of an ageing population infected with HIV: A modelling study publication-title: Lancet Infect Dis – volume: 96 start-page: 333 year: 2013 end-page: 360 article-title: Updated international consensus guidelines on the management of cytomegalovirus in solid‐organ transplantation publication-title: Transplantation – volume: 59 start-page: e96 year: 2014 end-page: e138 article-title: Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America publication-title: Clin Infect Dis – volume: 9 start-page: 1946 year: 2009 end-page: 1952 article-title: Safety and efficacy of raltegravir in HIV‐infected transplant patients cotreated with immunosuppressive drugs publication-title: Am J Transplant – volume: 34 start-page: S1 issue: S2 year: 2014 end-page: S92 article-title: Documento de consenso sobre la evaluación y manejo de la afectación renal en pacientes con infección por el VIH publication-title: Nefrología – volume: 24 start-page: 333 year: 2011 end-page: 343 article-title: Spanish experience as a leading country: What kind of measures were taken? publication-title: Transpl Int – year: 2015 – year: 2013 – ident: e_1_2_6_5_1 doi: 10.1681/ASN.2014070726 – ident: e_1_2_6_34_1 doi: 10.1089/aid.2007.0015 – ident: e_1_2_6_10_1 doi: 10.1093/cid/ciu617 – ident: e_1_2_6_21_1 doi: 10.7326/0003-4819-150-9-200905050-00006 – ident: e_1_2_6_17_1 doi: 10.5935/0101-2800.20120029 – ident: e_1_2_6_20_1 doi: 10.1093/ndt/gfs287 – ident: e_1_2_6_18_1 doi: 10.1111/tid.12592 – ident: e_1_2_6_6_1 doi: 10.1097/QAI.0000000000000291 – ident: e_1_2_6_26_1 doi: 10.1002/bjs.6607 – ident: e_1_2_6_16_1 doi: 10.1056/NEJMoa1408896 – ident: e_1_2_6_36_1 doi: 10.1111/ajt.13840 – ident: e_1_2_6_15_1 doi: 10.1056/NEJMc0900837 – ident: e_1_2_6_22_1 doi: 10.1111/j.1600-6143.2008.02159.x – ident: e_1_2_6_12_1 doi: 10.1038/ki.2010.545 – ident: e_1_2_6_37_1 doi: 10.1016/j.transproceed.2009.04.013 – ident: e_1_2_6_7_1 doi: 10.1111/j.1600-6143.2010.03258.x – volume: 26 start-page: 113 year: 2006 ident: e_1_2_6_13_1 article-title: Renal transplantation in HIV‐infected patients in Spain publication-title: Nefrología – ident: e_1_2_6_28_1 doi: 10.5123/S1679-49742012000300013 – ident: e_1_2_6_3_1 doi: 10.1016/S1473-3099(15)00056-0 – ident: e_1_2_6_32_1 doi: 10.1097/TP.0000000000000879 – ident: e_1_2_6_23_1 doi: 10.1097/TP.0b013e31829df29d – ident: e_1_2_6_9_1 doi: 10.1038/ki.2015.74 – ident: e_1_2_6_19_1 doi: 10.1111/j.1432-2277.2010.01204.x – ident: e_1_2_6_30_1 – ident: e_1_2_6_24_1 – ident: e_1_2_6_39_1 doi: 10.5935/0101-2800.20140049 – ident: e_1_2_6_4_1 doi: 10.1056/NEJMoa1001197 – ident: e_1_2_6_14_1 doi: 10.1111/j.1600-6143.2009.02684.x – ident: e_1_2_6_35_1 doi: 10.1111/j.1600-6143.2006.01238.x – ident: e_1_2_6_8_1 doi: 10.1093/ndt/gfq592 – volume: 34 start-page: S1 issue: 2 year: 2014 ident: e_1_2_6_11_1 article-title: Documento de consenso sobre la evaluación y manejo de la afectación renal en pacientes con infección por el VIH publication-title: Nefrología – ident: e_1_2_6_38_1 doi: 10.1681/ASN.2013050564 – ident: e_1_2_6_31_1 doi: 10.1681/ASN.2014121234 – ident: e_1_2_6_27_1 doi: 10.5935/0101-2800.20130048 – ident: e_1_2_6_2_1 doi: 10.1016/S0140-6736(13)61809-7 – volume-title: Trends in HCV Infection, Liver Disease Severity, and Specific Treatment Modalities among HIV+ patients: Madrid, Spain year: 2012 ident: e_1_2_6_29_1 – ident: e_1_2_6_33_1 doi: 10.1097/01.TP.0000436905.54640.8c – ident: e_1_2_6_25_1 doi: 10.1590/S0101-28002011000400014 |
SSID | ssj0017949 |
Score | 2.1606207 |
Snippet | Background
In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing... In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing countries... Background In the developed world, kidney transplantation (KT) in patients with human immunodeficiency virus (HIV) infection is well established. Developing... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
SubjectTerms | Acquired immune deficiency syndrome acute rejection Adult AIDS Anti-Retroviral Agents - therapeutic use Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Bacteria Bacterial infections Biopsy Brazil Calcineurin Calcineurin Inhibitors - therapeutic use Cohort analysis Cohort Studies Complications Demographics Demography Developing countries Drug Interactions Female Graft rejection Graft Survival Hepatitis Hepatitis C HIV HIV infection HIV Infections - complications HIV Infections - drug therapy HIV Infections - virology Human immunodeficiency virus Humans Immunosuppression Immunosuppressive Agents - therapeutic use Infections Ischemia Kidney Function Tests Kidney Transplantation Kidney transplants LDCs Male Middle Aged patient survival Patients Regional differences Rejection Retrospective Studies Spain Survival Transplantation Transplants & implants Treatment Outcome Viruses |
Title | Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3‐year retrospective cohort study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftid.12724 https://www.ncbi.nlm.nih.gov/pubmed/28508573 https://www.proquest.com/docview/1925518170 https://www.proquest.com/docview/1899406663 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELWqrtjwUHlcKNWAWHSTK8d2khtYVZSqIMGiaqUukCI_UdTWQbkJUlnxCfxH_6pfgsd5iPKQELsoHsuJM2OfcWbOEPIiIHy6KrhNOM_LRGhTJlJwl8jViivmdMYN5ju__5Afnoh3p9npBnk15cIM_BDzgRtaRlyv0cClWv9k5F1tlikrGHKBpjxH3vz9o5k6CvWsjM5WGTQh7NEjqxBG8cw9b-5FvwHMm3g1bjgHd8jH6VGHOJOzZd-ppf76C4vjf77LXXJ7BKKwN2jOPbJh_Ra5OrKf4tkgTIVTwjICtYcAE-FijpQB6Q00fReGsdA4OKuNt5fQRaL0czlkM3nsN9K2rgHPeyEWBIQaU1IaY5G7AhM_4Uvd9jjKEBbmX8Ie8Otv3y-DEUJru7aZ0kEBy_m2HURO3Pvk5ODN8evDZCznkGiecWRHDIuFddTllkmbS6pkkZdWK1cKKUWqbMBKwjFqREYZ-m1C5kpTnXJrCqr4A7LpG28fEWBKOZ2qlCphRMBgKpUu3KCGKpMVOluQ3enDVnrkOseSG-fV5POEGa_ijC_I81n080Dw8Seh7Uk7qtHG11XAxkhnlxZ0QZ7NzcE68ZeL9Lbpg0xwZwW6iHxBHg5aNY_CVhmWFwgtu1E3_j58dfx2P148_nfRJ-QWQwQSYxW3yWbX9vZpwE-d2omG8gOoqxvI |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELVKWcCGh3jdUmBALLrJlWM7yQ1iUwHVLbRdVLdSNyjyKyhqcao0QSorPoH_4K_4EjzOQ5SHhNhFiS0nzox9ZjxzhpDnHuHTRcZtxHmaR0KbPJKCl5FcLLhipU64wXzn_YN0eSTeHifHa-TlmAvT80NMDjfUjLBeo4KjQ_onLW8rM49ZxsQVcjWczyEkOpzIo1DS8mBu5V4W_C498AphHM_U9fJu9BvEvIxYw5azc5O8H1-2jzQ5mXetmuvPv_A4_u_X3CI3BiwK273w3CZr1t0h3w7th-AehLF2il9JoHLgkSJ8nIJlQDoDddf6cSzUJZxUxtkLaANX-qnsE5oc9huYW88BXb4QagJChVkptbFIX4G5n_CpajocpY8Mcy9gG_j3L18vvB5CY9umHjNCASv6Ni0EWty75GjnzerVMhoqOkSaJxwJEv16YUtappZJm0qqZJbmVqsyF1KKWFkPl0TJqBEJZWi6CZkqTXXMrcmo4vfIuqudfUCAKVXqWMVUCSM8DFOxLP0NaqgySaaTGdka_2yhB7pzrLpxWoxmj5_xIsz4jDybmp71HB9_arQ5ikcxqPl54eExMtrFGZ2Rp9Njr6B46iKdrTvfxlu0Aq1EPiP3e7GaRmGLBCsM-CdbQTj-Pnyx2n0dLjb-vekTcm252t8r9nYP3j0k1xkCkhC6uEnW26azjzycatXjoDU_AEMUH-Y |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwELVKkRAbCuLRSwsMiEU3uXJsJ7mBVUW5anlUqGqlLpAiP1HUklRpglRWfAL_wV_xJXichygPCbGL4rGcODP2GWfmDCFPPcKni4zbiPM0j4Q2eSQFd5FcLLhiTifcYL7z2_1090i8Ok6OV8jzMRem54eYDtzQMsJ6jQZ-ZtxPRt6WZh6zjIkr5KpI_TaJiOhg4o5CRcuDt5V7VfCb9EArhGE8U9fLm9FvCPMyYA07znKNvB-ftQ80OZl3rZrrz7_QOP7ny9wkNwYkCtu96twiK7a6Tb4d2A_hcBDGyil-HYGyAo8T4eMUKgOyMlB3rR_GQu3gpDSVvYA2MKWfyj6dqcJ-A2_rOeCBL4SKgFBiTkptLJJXYOYnfCqbDkfp48KqZ7AN_PuXrxfeCqGxbVOP-aCA9XybFgIp7h1ytHx5-GI3Guo5RJonHOkR_WphHXWpZdKmkiqZpbnVyuVCShEr68GScIwakVCGjpuQqdJUx9yajCp-l6xWdWXXCTClnI5VTJUwwoMwFUvnb1BDlUkynczI1vhhCz2QnWPNjdNidHr8jBdhxmfkySR61jN8_Eloc9SOYjDy88KDY-SzizM6I4-nZm-e-M9FVrbuvIz3ZwX6iHxG7vVaNY3CFgnWF_AtW0E3_j58cbi3Ey7u_7voI3Lt3c6yeLO3_3qDXGeIRkLc4iZZbZvOPvBYqlUPg838AN3JHpU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regional+differences+in+the+management+and+outcome+of+kidney+transplantation+in+patients+with+human+immunodeficiency+virus+infection%3A+A+3-year+retrospective+cohort+study&rft.jtitle=Transplant+infectious+disease&rft.au=Cristelli%2C+Marina+P&rft.au=Cof%C3%A1n%2C+Federico&rft.au=Tedesco-Silva%2C+Helio&rft.au=Trull%C3%A0s%2C+Joan+Carles&rft.date=2017-08-01&rft.issn=1399-3062&rft.eissn=1399-3062&rft.volume=19&rft.issue=4&rft_id=info:doi/10.1111%2Ftid.12724&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon |